1. Home
  2. ADPT
  3. ADPT News

Latest Adaptive Biotechnologies Corporation (ADPT) News on October 8, 2025

ADPT

MT Newswires

8 days ago

Guggenheim Initiates Coverage on Adaptive Biotechnologies With Buy Rating, $20 Price Target

The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook
ADPT

Simply Wall St.

10 days ago

The Bull Case For Adaptive Biotechnologies (ADPT) Could Change Following Analyst Upgraded Earnings Outlook

Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum
ADPT

Simply Wall St.

11 days ago

Adaptive Biotechnologies (ADPT): Exploring Valuation After Recent Share Price Momentum

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
ADPT

Zacks

12 days ago

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome
ADPT

Zacks

a month ago

IONS Up on FDA's Breakthrough Tag for ION582 in Angelman Syndrome

SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study
ADPT

Zacks

a month ago

SNY Down Despite Eczema Candidate Meeting Goal in Phase III Study

PTC drug for Friedrich’s ataxia rejected; Lilly sells nearly $7B in bonds
ADPT

BioPharma Dive

2 months ago

PTC drug for Friedrich’s ataxia rejected; Lilly sells nearly $7B in bonds

ADPT

MT Newswires

2 months ago

Adaptive Biotechnologies Shares Fall After Genentech Collaboration Termination

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?
ADPT

Zacks

3 months ago

Adaptive Biotechnologies (ADPT) Surges 12.5%: Is This an Indication of Further Gains?

Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy
ADPT

Insider Monkey

3 months ago

Craig-Hallum Initiates Coverage of Adaptive Biotechnologies (ADPT) stock, Gives Buy

Is Bio-Techne Stock Underperforming the Nasdaq?
ADPT

Barchart

3 months ago

Is Bio-Techne Stock Underperforming the Nasdaq?

ADPT

MT Newswires

4 months ago

Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock
ADPT

Zacks

4 months ago

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
ADPT

Zacks

4 months ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
ADPT

GlobeNewswire

4 months ago

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal
ADPT

Zacks

4 months ago

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot
ADPT

Zacks

4 months ago

U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
ADPT

GlobeNewswire

4 months ago

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

4 months ago

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz
ADPT

Zacks

5 months ago

BioMarin Offers to Buy Inozyme for $270M to Boost Enzyme Therapy Biz

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer
ADPT

Zacks

5 months ago

AbbVie Secures FDA Nod for New ADC Drug Emrelis in Lung Cancer

Allogene's Q1 Earnings In Line With Estimates, Sales Nil
ADPT

Zacks

5 months ago

Allogene's Q1 Earnings In Line With Estimates, Sales Nil

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?
ADPT

Zacks

5 months ago

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up
ADPT

Zacks

5 months ago

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?
ADPT

Zacks

5 months ago

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?
ADPT

Zacks

5 months ago

Has Adaptive Biotechnologies (ADPT) Outpaced Other Medical Stocks This Year?

ADPT

MT Newswires

5 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $502,828, According to a Recent SEC Filing

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57
ADPT

Simply Wall St.

5 months ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57

Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations
ADPT

Simply Wall St.

5 months ago

Adaptive Biotechnologies First Quarter 2025 Earnings: Beats Expectations

ADPT

MT Newswires

5 months ago

Sector Update: Health Care Stocks Higher Friday Afternoon

ADPT

MT Newswires

5 months ago

Adaptive Biotechnologies Shares Surge After Q1 Loss Narrows, Revenue Rises

ADPT

Thomson Reuters StreetEvents

5 months ago

Q1 2025 Adaptive Biotechnologies Corp Earnings Call

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...
ADPT

GuruFocus.com

5 months ago

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

5 months ago

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
ADPT

Zacks

5 months ago

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

5 months ago

Adaptive Biotechnologies: Q1 Earnings Snapshot

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
ADPT

GlobeNewswire

5 months ago

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

OpenAI And Andreessen Horowitz Lead $43M Round For Cybersecurity Startup Taking On AI Scammers, Deepfakes, And Voice Spoofs
ADPT

Benzinga

6 months ago

OpenAI And Andreessen Horowitz Lead $43M Round For Cybersecurity Startup Taking On AI Scammers, Deepfakes, And Voice Spoofs

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025
ADPT

GlobeNewswire

6 months ago

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

ADPT

MT Newswires

6 months ago

Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma
ADPT

GlobeNewswire

6 months ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close

ADPT

MT Newswires

7 months ago

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March
ADPT

Insider Monkey

7 months ago

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma
ADPT

GlobeNewswire

7 months ago

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $1,600,417, According to a Recent SEC Filing

ADPT

MT Newswires

7 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $2,410,700, According to a Recent SEC Filing

ADPT

MT Newswires

8 months ago

Adaptive Biotechnologies Insider Sold Shares Worth $3,985,754, According to a Recent SEC Filing

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank
ADPT

TipRanks

8 months ago

Adaptive Biotechnologies price target raised to $12 from $10 at Scotiabank

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations
ADPT

Simply Wall St.

8 months ago

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade
ADPT

Zacks

8 months ago

Adaptive Biotechnologies (ADPT) Moves to Buy: Rationale Behind the Upgrade

ADPT

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?
ADPT

Zacks

8 months ago

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...
ADPT

GuruFocus.com

8 months ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

8 months ago

Adaptive Biotechnologies (ADPT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates
ADPT

Zacks

8 months ago

Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates

ADPT

MT Newswires

8 months ago

Adaptive Biotechnologies' Q4 Loss Narrows, Revenue Rises

ADPT

Associated Press Finance

8 months ago

Adaptive Biotechnologies: Q4 Earnings Snapshot

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results
ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For
ADPT

GuruFocus.com

8 months ago

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Report Preview: What To Look For

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
ADPT

GlobeNewswire

8 months ago

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI
ADPT

Clinical Trials Arena

8 months ago

PhaseV and Alimentiv to support execution of adaptive clinical trials for GI

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%
ADPT

Simply Wall St.

8 months ago

The 5.4% return this week takes Adaptive Biotechnologies' (NASDAQ:ADPT) shareholders one-year gains to 99%

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now
ADPT

Insider Monkey

8 months ago

Why Adaptive Biotechnologies Corporation (ADPT) Is Skyrocketing Now

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?
ADPT

Insider Monkey

8 months ago

Why Is Andreas Halvorsen Bullish On Adaptive Biotechnologies Corporation (ADPT) Now?

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?
ADPT

Zacks

9 months ago

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
ADPT

Zacks

9 months ago

Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?

ADPT

MT Newswires

9 months ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ADPT

GlobeNewswire

9 months ago

Adaptive Biotechnologies to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

9 months ago

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?
ADPT

Zacks

10 months ago

Are Medical Stocks Lagging BellRing Brands (BRBR) This Year?

Adaptive unveils data of MRD assessment test in blood cancer treatment
ADPT

Medical Device Network

10 months ago

Adaptive unveils data of MRD assessment test in blood cancer treatment

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions
ADPT

GlobeNewswire

10 months ago

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area
ADPT

Clinical Trials Arena

10 months ago

Adaptive Research and WRO to expand cancer trial access in San Francisco Bay Area

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting
ADPT

GlobeNewswire

10 months ago

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

10 months ago

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?

Novotech report notes shift to adaptive designs in clinical trials
ADPT

Clinical Trials Arena

10 months ago

Novotech report notes shift to adaptive designs in clinical trials

Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know
ADPT

Zacks

a year ago

Wall Street Analysts Predict a 31.36% Upside in Adaptive Biotechnologies (ADPT): Here's What You Should Know

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
ADPT

Zacks

a year ago

Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations
ADPT

Simply Wall St.

a year ago

Adaptive Biotechnologies Third Quarter 2024 Earnings: Beats Expectations

ADPT

Thomson Reuters StreetEvents

a year ago

Q3 2024 Adaptive Biotechnologies Corp Earnings Call

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...
ADPT

GuruFocus.com

a year ago

Adaptive Biotechnologies Corp (ADPT) Q3 2024 Earnings Call Highlights: Strong MRD Growth Amidst ...

Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates
ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates

ADPT

Associated Press Finance

a year ago

Adaptive Biotechnologies: Q3 Earnings Snapshot

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Assessing Measurable Residual Disease in Mantle Cell Lymphoma

Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result
ADPT

GuruFocus.com

a year ago

Earnings To Watch: Adaptive Biotechnologies Corp (ADPT) Reports Q3 2024 Result

November 2024's Top US Penny Stocks With Growth Potential
ADPT

Simply Wall St.

a year ago

November 2024's Top US Penny Stocks With Growth Potential

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Report Third Quarter 2024 Financial Results on November 7, 2024

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?
ADPT

Zacks

a year ago

Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year?

Parametric company Adaptive Insurance launches operations
ADPT

Life Insurance International

a year ago

Parametric company Adaptive Insurance launches operations

ADPT

MT Newswires

a year ago

Adaptive Biotechnologies Receives IVDR Certification for clonoSEQ

Adaptive Announces IVDR Certification for clonoSEQ® in European Union
ADPT

GlobeNewswire

a year ago

Adaptive Announces IVDR Certification for clonoSEQ® in European Union

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
ADPT

GlobeNewswire

a year ago

Adaptive Biotechnologies to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
ADPT

Zacks

a year ago

Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates

Share on Social Networks: